LeMaitre Vascular, Inc. (LMAT)
107.83
-2.39
(-2.17%)
USD |
NASDAQ |
May 07, 16:00
107.83
0.00 (0.00%)
After-Hours: 20:00
LeMaitre Vascular Research and Development Expense (Annual) : 14.14M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Apyx Medical Corp. | 3.373M |
| Integer Holdings Corp. | 46.35M |
| Intuitive Surgical, Inc. | 1.312B |
| Globus Medical, Inc. | 146.94M |
| PROCEPT BioRobotics Corp. | 71.28M |